Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • US health

    Tag: us health

    You Searched For "US health"
    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Medical Dialogues Bureau18 Jun 2019 1:57 PM IST
    New Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
    Natco Pharma- Kothur facility gets 9 observations from USFDA

    Natco Pharma- Kothur facility gets 9 observations from USFDA

    Medical Dialogues Bureau7 Jun 2019 2:21 PM IST
    NEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    Cipla gets no USFDA observations for Indore facility

    Cipla gets no USFDA observations for Indore facility

    Farhat Nasim18 May 2019 9:45 AM IST
    The US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Farhat Nasim13 May 2019 10:31 AM IST
    Zydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Farhat Nasim9 May 2019 10:15 AM IST
    Unichem Lab's approved drug is a generic copy of Zyrtec-D 12 Hour which is used for treating allergic rhinitis.New Delhi: Unichem Laboratories Tuesday...
    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Medical Dialogues Bureau1 May 2019 8:05 PM IST
    New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
    Trump to keep fighting opioids

    Trump to keep fighting opioids 'until our job is done'

    Medical Dialogues Bureau28 April 2019 9:00 AM IST
    While prescription opioids initially accounted for most deaths, the epidemic is now driven by illicit heroin and fentanyl.ATLANTA: President Donald...
    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Medical Dialogues Bureau26 April 2019 8:59 AM IST
    Phentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
    Alkem Labs gets 8 USFDA observations for St Louis facility

    Alkem Labs gets 8 USFDA observations for St Louis facility

    Farhat Nasim24 March 2019 9:50 AM IST
    The United States Food and Drug Administration (USFDA) had issued eight observations after inspecting the company's manufacturing plant at St Louis...
    Lupin Somerset facility gets OAI letter from USFDA

    Lupin Somerset facility gets OAI letter from USFDA

    Farhat Nasim18 March 2019 9:25 AM IST
    "The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending...
    USFDA Caution: Lupin gets OAI letter for MP plant

    USFDA Caution: Lupin gets OAI letter for MP plant

    Medical Dialogues Bureau17 March 2019 9:45 AM IST
    Lupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Mandideep (Unit 1) facility...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok